1-hexadecanoyl-2-(13Z-docosenoyl)-sn-glycero-3-phosphoethanolamine

Metabolite details

Identifier

XMJSNHMFTISTET-AFASEBMKSA-N

InChI Key

XMJSNHMFTISTET-AFASEBMKSA-N

IUPAC name

(19R)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22λ⁵-phosphapentacosan-19-yl (13Z)-docos-13-enoate

Preferred name

1-hexadecanoyl-2-(13Z-docosenoyl)-sn-glycero-3-phosphoethanolamine

INN name

—

Synonym

phosphatidylethanolamine(16:0/22:1(13Z))

ChEBI

CHEBI:73875

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_AONFH_Stage_III_IV
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT